Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label Olysio plus Sovaldi. Show all posts
Showing posts with label Olysio plus Sovaldi. Show all posts

Monday, April 20, 2015

Egypt: New hep C treatment to hit Egyptian market in May

CAIRO: A new drug for treating hepatitis C will be available on the Egyptian market early next month, Health Minister Adel al-Adawy announced Monday.

A 30,000-dose shipment of Olisio, the new treatment, has arrived in Egypt, and is currently undergoing tests before release on the market, the head of National Committee for the Control of Viral Hepatitis Waheed Doss told Youm 7.

Doss added that once Olisio is approved, the treatment protocol will be changed and the new drug will be used simultaneously with the currently-used American-made Sovaldi.

Read more...

Monday, March 2, 2015

McHenry man cured of hepatitis through new drugs

McHENRY – Ray Roach reflects on the grim prognosis a doctor delivered to him during a hospital stay nearly four years ago and smiles.

He smiles a lot these days, in fact. Twisting free of a noose will do that for a person.

Roach, 52, of McHenry is among the first of a new crop of patients celebrating a remarkable cure. Diagnosed at age 46 with Hepatitis C, a liver disease caused by the Hepatitis C virus, Roach spent years on a health see-saw, and at one point, was near death.